Breathalyzer test detects lung cancer 90% accuracy

Breathalyzer Test May Detect Deadliest Cancer — Researchers from TAU and partner institutions develop groundbreaking device that spots lung cancer – to stop it in its tracks – A new device developed by a team of Israeli, American, and British cancer researchers may turn the tide by both accurately detecting lung cancer and identifying its stage of progression.

Preventing disparities in colon cancer screening

How to prevent disparities in colon cancer screening – People living in poverty are less likely to be screened regularly for colorectal cancer — and more likely to develop the disease and die from it. How to end these disparities — and raise screening rates, lower disease rates, and prevent deaths?

Mammography screening for breast cancer needs individualized approach

The mammography dilemma — Complex benefits and harms of mammography require individualized approach – A comprehensive review of 50 year’s worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.

Screen high risk populations for lung cancer – final lung cancer screening recommendations

Final recommendations on lung cancer screening — Final word: Task Force says screen high-risk populations for lung cancer – High-risk adults between the ages of 55 and 80 should receive annual lung cancer screening with low-dose computed tomography, according to final recommendations from the U.S. Preventive Services Task Force being published in Annals of Internal Medicine.

New therapeutic targets for treating Parkinson’s disease

Gene-silencing study finds new targets for Parkinson’s disease — NIH study sheds light on treatment of related disorders – Scientists at the National Institutes of Health have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson’s disease. The findings also may be relevant to several diseases caused by damage to mitochondria, the biological power plants found in cells throughout the body.

Biomarker CA-125 shows promise as screening tool for early detection of ovarian cancer

CA-125 change over time shows promise as screening tool for early detection of ovarian cancer — Blood test used to find recurrence uncovers invasive, high-grade disease at curable stage – CA-125, the protein recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease of ovarian cancer. The simple blood test could offer a much-needed screening tool to detect ovarian cancer in its early stages – even in the most aggressive forms.

Personalized Strategies to Reduce Cancer Overtreatment

Major Changes Urged for Cancer Screening and Treatment — Scientific Panel Recommends New Personalized Strategies to Reduce Cancer Overtreatment – To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”

New genomic prostate cancer test improves risk assessment and surveillance

New prostate cancer test improves risk assessment — Tool tested by UC San Francisco helps identify those best suited for active surveillance – A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance – a way of managing the disease without direct treatment.

HIV screening for all adults, adolescents, and pregnant aged 15-65

US Task Force Says Screen All Adults, Adolescents, and Pregnant Women for HIV – New recommendations from the United States Preventive Services Task Force (USPSTF) urge physicians to screen all adults and adolescents aged 15 – 65 for HIV. In addition, all pregnant women should receive screening, even those who are in labor but have not yet been screened.